No products in the cart.
Return To ShopNo products in the cart.
Return To ShopBRILINTA 90 MG, developed by AstraZeneca, is primarily an antiplatelet medication. It is often prescribed to patients with acute coronary syndromes or a history of heart attacks, helping to reduce the risk of future cardiovascular events. The mechanism of action involves the inhibition of platelet aggregation, which is crucial in preventing blood clots. This feature makes BRILINTA essential in the management of various cardiovascular conditions. For athletes or individuals engaged in strenuous physical activities, understanding its role in cardiovascular health is vital, particularly when considering its impact on overall fitness and endurance.
The active ingredient in BRILINTA, ticagrelor, works by blocking P2Y12 adenosine diphosphate (ADP) receptors on platelets. This inhibition leads to a reduction in platelet activation and aggregation, helping to prevent thrombus formation. For athletes, the implications of this action extend beyond just heart health. Improved blood flow can enhance oxygen delivery to muscles during intense training sessions, potentially improving endurance and performance.
Moreover, with increased circulation, muscle tone may also benefit from better nutrient delivery and waste removal. While typically used more in medical settings, these effects can be intriguing for regulated athletes seeking a competitive edge or those recovering from cardiac events attempting to return to their training and sports activities. Athletes must consult healthcare professionals before considering BRILINTA to avoid any potential misuse or unintended consequences.
When looking to purchase BRILINTA 90 MG, it is essential to ensure that you are sourcing it from a reputable supplier. Here are some essential steps to consider:
Following these steps can help ensure that your purchase of BRILINTA 90 MG is safe and legitimate, maintaining your health as you manage any cardiovascular concerns during your training.
BRILINTA offers several compelling benefits, particularly for individuals recovering from cardiovascular incidents or athletes looking to ensure their well-being. One significant advantage is its ability to lower the risk of major cardiovascular events, such as heart attacks and strokes. This function is essential for maintaining a healthy lifestyle, allowing athletes to focus on their training without the worry of underlying heart issues.
Additionally, the quick onset of action of BRILINTA means that it can be effective shortly after administration, which is beneficial for those requiring immediate intervention. The side effects are generally manageable, with routine monitoring making it easier for healthcare providers to ensure patient safety. Importantly, the improved circulation due to its mechanism can enhance overall performance, making this medication a topic of interest for athletes interested in optimizing their training efficiency.
Despite its advantages, BRILINTA is not suitable for everyone. There are specific contraindications that potential users must be aware of:
It’s crucial for anyone considering this product, especially athletes, to discuss these contraindications with their healthcare provider to ensure safety and efficacy in their personal health plan.
| Active substance | Ticagrelor |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Low risk |
| Lab Test | Not specific, may monitor platelet function tests |
| Also known as | AZD6140 |
| Blood pressure | Can cause transient increase |
| Trade name | Brilinta, Brilique, Possia |
| FORM | 56 pills x 90 mg |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (1S,2S,3R,5R)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Formula | C23H28F2N6O4S |
| Substance class | Antiplatelet agent |
| Main action | Platelet aggregation inhibitor |
| Half-life | Approximately 7 to 8.5 hours |
| Dosage (medical) | Typically 90 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces the rate of stent thrombosis in patients who are at risk, decreases myocardial infarction |
| Side effects | Bleeding, dyspnea, headache, cough, hypertension, nausea |
| Use in sports | Not typically used in sports |
| Manufacturer | AstraZeneca |
€82.00
Copyright © 2026 cyclecorex.com
Select at least 2 products
to compare
Reviews
There are no reviews yet.